IRIS PubliCatt

Caldarola, Giacomo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.779
EU - Europa 2.655
AS - Asia 986
AF - Africa 42
OC - Oceania 13
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.491
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.751
DE - Germania 949
SE - Svezia 458
CN - Cina 401
SG - Singapore 357
IT - Italia 273
UA - Ucraina 240
FR - Francia 166
IE - Irlanda 155
FI - Finlandia 125
ID - Indonesia 109
GB - Regno Unito 92
RU - Federazione Russa 66
IN - India 53
PL - Polonia 44
BE - Belgio 26
EG - Egitto 22
CI - Costa d'Avorio 20
TR - Turchia 20
CA - Canada 19
HK - Hong Kong 12
JP - Giappone 12
NL - Olanda 12
BR - Brasile 11
CZ - Repubblica Ceca 11
AT - Austria 8
NZ - Nuova Zelanda 8
IR - Iran 7
ES - Italia 6
RO - Romania 6
AU - Australia 5
MX - Messico 5
MY - Malesia 5
EU - Europa 4
LT - Lituania 3
NO - Norvegia 3
PA - Panama 3
CY - Cipro 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
VN - Vietnam 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
DK - Danimarca 1
GT - Guatemala 1
IQ - Iraq 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MK - Macedonia 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
TW - Taiwan 1
Totale 6.491
Salva come PNG Salva come JPEG
Città #
Chandler 682
Singapore 274
Ashburn 230
Dublin 151
Jacksonville 141
San Mateo 132
Jakarta 109
Nanjing 92
New York 91
Wilmington 81
Ann Arbor 79
Helsinki 67
Woodbridge 67
Dearborn 61
Boston 60
Bremen 57
Milan 57
Munich 52
Houston 51
Nürnberg 48
Cattolica 47
Princeton 46
Rome 45
Boardman 41
Kraków 41
Lawrence 41
Beijing 40
Moscow 40
Nanchang 32
Redwood City 31
Seattle 31
Los Angeles 29
Marseille 27
Fairfield 26
Paris 25
Brussels 23
Abidjan 20
Leawood 19
Kunming 18
Hebei 17
Redmond 16
Detroit 15
Norwalk 14
London 13
Shenyang 13
Chicago 12
Frankfurt am Main 12
Shanghai 12
Izmir 11
Tianjin 11
Changsha 10
Falkenstein 10
Hong Kong 10
Jiaxing 10
Mountain View 10
University Park 10
Zhengzhou 10
Brno 9
Guangzhou 9
Augusta 8
Ottawa 8
Toronto 8
Vienna 8
Cairo 7
Fremont 7
Hangzhou 7
Lancaster 7
Washington 7
Esslingen am Neckar 6
Ypsilanti 6
Amsterdam 5
As Santah 5
Auckland 5
Boydton 5
Feasterville Trevose 5
Hyderabad 5
Lappeenranta 5
Pune 5
Simi Valley 5
Southampton 5
Zefta 5
Ankara 4
Ardabil 4
Brooklyn 4
Changchun 4
Englewood 4
Falls Church 4
Sydney 4
Al Mansurah 3
Andover 3
Aurora 3
Bologna 3
Brasov 3
Bregano 3
Camden 3
Chongqing 3
Cosenza 3
Hefei 3
Lanzhou 3
Monterrey 3
Totale 3.636
Salva come PNG Salva come JPEG
Nome #
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. 165
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 155
Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study. 146
Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis 122
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 115
Linear atrophoderma of Moulin 113
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study 113
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes 110
Exacerbation of pemphigus after influenza vaccination. 108
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data. 106
A glass of red wine to keep vascular disease at bay, but what about pemphigus vulgaris? 105
Usefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis. 105
Circulating endothelial cell levels in psoriatic patients and their modification after an anti-TNF-alpha (Etanercept) treatment 105
Circumscribed pityriasis rubra pilaris type IV 102
HLA-Cw6 allele, NFkB1 and NFkBIA polymorphisms play no role in predicting response to etanercept in psoriatic patients 102
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 101
Tacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label study 100
Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study 98
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 96
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 94
Management of recurrent cutaneous abscesses during therapy with infliximab 93
Evaluation of Endothelial Dysfunction in Psoriatic Patients by Different Techniques 87
TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients 87
Clinical predictors of nonresponse to anti-TNF-α agents in psoriatic patients: A retrospective study 86
Lichenoid reaction induced by adalimumab 84
Clinical and ultrasonographic profile of adalimumab-treated hidradenitis suppurativa patients: A real-life monocentric experience 83
IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses 82
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 82
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 82
Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports 79
Psychopathology and eating disorders in patients with psoriasis 78
TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept 76
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 76
Dyshidrosiform pemphigoid: a well-defined clinical entity? 75
Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy 75
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 75
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 74
Etanercept therapy for psoriasis in a patient with numerous comorbidities 73
Melanoma onset after estrogen, thyroid, and growth hormone replacement therapy. 71
Dermoscopy of cutaneous sarcoidosis. 71
Herpes simplex virus infection in pemphigus vulgaris: clinical and immunological considerations 68
Human leukocyte antigen-B*58:01 allele in a familial case of Stevens-Johnson syndrome induced by allopurinol 68
Lichen sclerosus of the glans simulating melanoma 68
development of pemphigus vulgaris in a patient with psoriasis treated with cyclosporine 67
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 64
Psoriasis and erythema nodosum: two comorbidities of inflammatory bowel diseases 64
Childhood trauma and resilience in psoriatic patients: A preliminary report 64
Role of personalized medication training in improving efficacy and adherence to a topical therapy 64
A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic 63
Biological agents targeting interleukin-13 for atopic dermatitis 62
Dermoscopy of melanocytic lesions in patients affected by oculocutaneous albinism: a case series 61
Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients 61
Clinico-dermoscopic features of alopecia areata in patients with psoriasis 57
A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasis 56
Dermoscopy of necrobiosis lipoidica and granuloma annulare 55
Untreated Psoriasis Impairs Male Fertility: A Case-Control Study 55
Psoriasis and polycystic ovary syndrome: A new link in different phenotypes 55
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature 55
New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination 53
New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis 52
Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy 52
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 50
Childhood trauma and resilience in psoriatic patients: A preliminary report. 50
A case of chronic disseminated lupus erythematosus in a psoriatic patient receiving ustekinumab 50
Prevalence of cutaneous comorbidities in psoriatic patients and their impact on quality of life. 49
Granuloma faciale: a case report on long-term treatment with topical tacrolimus and dermoscopic aspects 47
Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice 47
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy 47
Psoriasis and erythema nodosum: two comorbidities of inflammatory bowel diseases 46
Ixekizumab exposure associated with myelitis: A case report and a literature review 46
Linear IgA bullous dermatosis and ulcerative colitis treated by proctocolectomy 45
Tildrakizumab in moderate-to-severe plaque psoriasis: A multicenter, retrospective, real-life study 42
Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study 41
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study 41
Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study 40
Severe and resistant palmar psoriasis successfully treated with risankizumab 39
Multiple eruptive plaque-like dermatofibromas during anti-TNFα treatment 38
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy 38
IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses 37
Recalcitrant Sweet Syndrome successfully treated with adalimumab 37
Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab-induced psoriasis 36
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy 35
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 34
Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study 33
A case of guttate psoriasis during treatment with dupilumab 32
The preclinical discovery and development of deucravacitinib for the treatment of psoriasis 30
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 29
Multiple paradoxical reactions during ixekizumab therapy 27
Living with chronic spontaneous urticaria in Italy: A narrative medicine project to improve the pathway of patient care 25
Annular elastolytic giant cell granuloma following herpes zoster infection 25
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis) 24
2-Year Experience with Risankizumab in the Treatment of Plaque Psoriasis in Lazio Region, Italy 23
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 22
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies 21
Drug survival of biologics and non-biologics in patients affected by palmoplantar psoriasis: a “real-world”, mono-center experience 20
Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study 20
A case of eczematous eruption occurring during treatment with risankizumab 18
Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patients 18
Drug survival of methotrexate and predictor factors for discontinuation in psoriasis 15
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: A 52-week Italian real-life experience 14
Totale 6.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.147
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020311 0 0 0 0 0 0 78 29 37 17 79 71
2020/2021511 14 62 13 53 69 24 51 40 62 16 99 8
2021/2022665 75 54 20 19 33 20 10 113 16 40 129 136
2022/20231.782 218 255 117 280 145 221 64 139 237 22 60 24
2023/2024980 41 235 41 135 29 122 55 45 16 36 121 104
2024/2025714 59 60 178 67 182 168 0 0 0 0 0 0
Totale 6.603